Tag: NVT

Blue Sail Medical and Biosensors International acquire TAVI company NVT

Blue Sail Medical has completed the acquisition of Swiss based company NVT AG. The closure of the deal was publicly announced on the Shenzhen...

EuroPCR 2019: Allegra Transcatheter Heart Valve shows “very good haemodynamic outcomes”

Ulrich Schäfer (Hamburg, Germany) speaks to Cardiovascular News at EuroPCR (21–24 May, Paris) about the VIVALL study which looked at the safety and efficacy...

CE mark granted to NVT for Allegra transcatheter aortic valve

NVT has received the CE mark for its Allegra transcatheter aortic valve, which it describes as “distinctive” in a company release. The product features...

Novel tricuspid therapy wins the 2016 EACTS Techno College Innovation Award

A novel device for treating tricuspid regurgitation has become the 2016 recipient of the European Association for Cardio-Thoracic Surgery (EACTS) Techno College Innovation Award....

PCRLV 2016: New approaches to TAVI are still being explored

Although much of the innovation in transcatheter solutions for structural heart disease is now focused on mitral and tricuspid approaches, novel devices for transcatheter...